CSF3 and Axenfeld-Rieger syndrome: The approval of granulocyte colony stimulating factor treatments (G-CSF), filgrastim and pegfilgrastim, for the treatment of acute radiation syndrome (ARS) provides an example of the challenges associated with combining preclinical and clinical data together to identify the proper dosing under the Animal Rule.